These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15127807)

  • 1. Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.
    Wen X; Tan F; Jing Z; Liu Z
    J Pharm Biomed Anal; 2004 Feb; 34(3):517-23. PubMed ID: 15127807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on formulation development of mouth dissolving tablets of Carvedilol.
    Pokharkar V; Dhar S; Mandpe L
    Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):21-8. PubMed ID: 19957540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol.
    Beattie K; Phadke G; Novakovic J
    Profiles Drug Subst Excip Relat Methodol; 2013; 38():113-57. PubMed ID: 23668404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages.
    Alonso EC; Riccomini K; Silva LA; Galter D; Lima EM; Durig T; Taveira SF; Martins FT; Cunha-Filho MS; Marreto RN
    J Pharm Pharmacol; 2016 Oct; 68(10):1299-309. PubMed ID: 27465985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
    Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and study on the solid inclusion complex of sparfloxacin with HP-beta-cyclodextrin.
    Chao J; Li J; Meng D; Huang S
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Mar; 59(4):705-11. PubMed ID: 12609618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and spectroscopic studies of an inclusion complex of adenine with beta-cyclodextrin in solution and in the solid state.
    Hao X; Liang C; Jian-Bin C
    Analyst; 2002 Jun; 127(6):834-7. PubMed ID: 12146920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and study on the solid inclusion complex of sparfloxacin with beta-cyclodextrin.
    Chao JB; Tong HB; Huang SP; Liu DS
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 Jan; 60(1-2):161-6. PubMed ID: 14670473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and study on the novel solid inclusion complex of ciprofloxacin with HP-beta-cyclodextrin.
    Chao J; Meng D; Li J; Xu H; Huang S
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 Feb; 60(3):729-34. PubMed ID: 14747100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and study on the solid inclusion complex of ciprofloxacin with beta-cyclodextrin.
    Jianbin C; Liang C; Hao X; Dongpin M
    Spectrochim Acta A Mol Biomol Spectrosc; 2002 Nov; 58(13):2809-15. PubMed ID: 12477024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol: solubilization and cyclodextrin complexation: a technical note.
    Loftsson T; Vogensen SB; Desbos C; Jansook P
    AAPS PharmSciTech; 2008; 9(2):425-30. PubMed ID: 18431667
    [No Abstract]   [Full Text] [Related]  

  • 12. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
    Rawat S; Jain SK
    Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits.
    Aljimaee YH; El-Helw AR; Ahmed OA; El-Say KM
    Drug Des Devel Ther; 2015; 9():1379-92. PubMed ID: 25834396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-beta-cyclodextrin.
    Vlachou M; Papaïoannou G
    J Biomater Appl; 2003 Jan; 17(3):197-206. PubMed ID: 12614084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.
    Yuvaraja K; Khanam J
    J Pharm Biomed Anal; 2014 Aug; 96():10-20. PubMed ID: 24705456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir.
    Boudad H; Legrand P; Lebas G; Cheron M; Duchêne D; Ponchel G
    Int J Pharm; 2001 May; 218(1-2):113-24. PubMed ID: 11337155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Activity of Hydroxypropyl-β-Cyclodextrin and Water-Soluble Carriers on the Solubility of Carvedilol.
    Zoghbi A; Geng T; Wang B
    AAPS PharmSciTech; 2017 Nov; 18(8):2927-2935. PubMed ID: 28432614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation.
    Ficarra R; Tommasini S; Raneri D; Calabrò ML; Di Bella MR; Rustichelli C; Gamberini MC; Ficarra P
    J Pharm Biomed Anal; 2002 Aug; 29(6):1005-14. PubMed ID: 12110385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hot-melt extrusion as a continuous manufacturing process to form ternary cyclodextrin inclusion complexes.
    Thiry J; Krier F; Ratwatte S; Thomassin JM; Jerome C; Evrard B
    Eur J Pharm Sci; 2017 Jan; 96():590-597. PubMed ID: 27687637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and spectral investigation on inclusion complex of beta-cyclodextrin with rutin.
    Haiyun D; Jianbin C; Guomei Z; Shaomin S; Jinhao P
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Dec; 59(14):3421-9. PubMed ID: 14607238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.